Sartorius Stedim Biotech S.A. (ETR:56S1)
Germany
· Delayed Price · Currency is EUR 168.05
+2.65 (1.60%)
Last updated: Apr 15, 2025
Sartorius Stedim Biotech Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 14, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 18,210 | 18,363 | 22,073 | 27,883 | 44,467 | 26,843 | Upgrade
|
| Market Cap Growth | -31.01% | -16.81% | -20.84% | -37.29% | 65.66% | 97.16% | Upgrade
|
| Enterprise Value | 20,471 | 20,749 | 25,782 | 28,964 | 44,979 | 27,038 | Upgrade
|
| Last Close Price | 186.70 | 183.17 | 238.28 | 303.97 | 488.39 | 44.27 | Upgrade
|
| PE Ratio | 89.13 | 104.87 | 71.14 | 31.83 | 107.31 | 79.91 | Upgrade
|
| PS Ratio | 6.37 | 6.61 | 7.95 | 7.98 | 15.40 | 14.05 | Upgrade
|
| PB Ratio | 4.54 | 4.56 | 8.26 | 11.09 | 25.66 | 18.37 | Upgrade
|
| P/TBV Ratio | - | - | - | 46.41 | 163.54 | 112.24 | Upgrade
|
| P/FCF Ratio | 31.20 | 38.63 | 80.91 | 153.46 | 117.67 | 104.17 | Upgrade
|
| P/OCF Ratio | 20.70 | 22.53 | 29.57 | 45.54 | 63.35 | 64.39 | Upgrade
|
| EV/Sales Ratio | 7.16 | 7.46 | 9.29 | 8.29 | 15.58 | 14.16 | Upgrade
|
| EV/EBITDA Ratio | 29.88 | 32.97 | 39.20 | 24.20 | 43.61 | 46.83 | Upgrade
|
| EV/EBIT Ratio | 48.95 | 52.40 | 54.93 | 27.47 | 48.88 | 53.74 | Upgrade
|
| EV/FCF Ratio | 35.08 | 43.65 | 94.51 | 159.41 | 119.02 | 104.93 | Upgrade
|
| Debt / Equity Ratio | 0.73 | 0.71 | 1.38 | 0.45 | 0.36 | 0.40 | Upgrade
|
| Debt / EBITDA Ratio | 4.23 | 4.38 | 5.39 | 0.93 | 0.60 | 1.00 | Upgrade
|
| Debt / FCF Ratio | 5.03 | 6.04 | 13.50 | 6.25 | 1.66 | 2.28 | Upgrade
|
| Asset Turnover | 0.34 | 0.35 | 0.43 | 0.78 | 0.85 | 0.81 | Upgrade
|
| Inventory Turnover | 2.06 | 2.01 | 1.62 | 1.85 | 2.13 | 2.27 | Upgrade
|
| Quick Ratio | 1.04 | 1.05 | 0.49 | 0.53 | 0.59 | 0.59 | Upgrade
|
| Current Ratio | 1.85 | 1.85 | 1.51 | 1.61 | 1.40 | 1.54 | Upgrade
|
| Return on Equity (ROE) | 5.25% | 5.33% | 12.05% | 41.43% | 25.94% | 25.56% | Upgrade
|
| Return on Assets (ROA) | 3.19% | 3.10% | 4.59% | 14.62% | 16.90% | 13.38% | Upgrade
|
| Return on Capital (ROIC) | 3.81% | 3.74% | 5.86% | 21.93% | 26.10% | 18.63% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.80% | 5.40% | 6.90% | 26.20% | 31.60% | 22.00% | Upgrade
|
| Earnings Yield | 112.19% | 0.95% | 1.41% | 3.14% | 0.93% | 1.25% | Upgrade
|
| FCF Yield | 320.49% | 2.59% | 1.24% | 0.65% | 0.85% | 0.96% | Upgrade
|
| Dividend Yield | 41.06% | 0.38% | 0.29% | 0.47% | 0.26% | 1.54% | Upgrade
|
| Payout Ratio | 3284.38% | 38.32% | 42.77% | 13.25% | 15.13% | 9.33% | Upgrade
|
| Buyback Yield / Dilution | -363.90% | -5.01% | 0.00% | 0.01% | 0.00% | -0.00% | Upgrade
|
| Total Shareholder Return | -322.84% | -4.63% | 0.29% | 0.49% | 0.26% | 1.53% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.